| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |